109-44-4 | Sigma-Aldrich

Data Sheet - F3290

BioTechniques, 16(4): 730-735 (1994). 2. Antonysamy, S. et al., Proc. Nat. Acad. Sci. USA, 109(44): 17960-17965 (2012). 3. He, J. et al., Nucleic Acids Res., 40(13): 6097-6108 (2012). 4. Singh

MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors

FGF21 Musclin Frac std 4 21 1108 17 15 109 43 27 91 15 45 25 32 29 122 27 20 1115 16 16 113 43 27 100 15 44 26 35 30 133 27 std

Suspension MDCK Cell Culture in EX-CELL MDCK Serum-Free Medium

infection conditions produced peak TCID50 titers in the range of 108 - 109 particles/mL between 72 - 96 hours post-infection (Figure 4). Summary EX-CELLTM MDCK is a serum-free medium developed for adherent

Prohibited Substances Korean

n-Propyl chloroformate; 109-61-5] 및 이를 25% 이상 함유한 혼합물질 급성 흡입독성, 인화성 액체 2019-29 n-부틸아민[n-Butylamine ; 109-73-9] 및 이를 25% 이상 함유한 혼합물 급성 흡입독성, 인화성 액체 2019-30 말로노니트릴[Malononitrile; 109-77-3] 및 이를 25% 이상

Data Sheet - MAB1637

familial ALS. J. Neurosci. Res. 77(4): 573-582. Liour, S and Yu, RK. (2003). Differentiation of Radial Glia-Like cells from embryonic Stem Cells. GLIA 42(2): 109-117. Mitsui, K. et al. (2002). Purification

Quality Control Range Sheet- TH17-112 and TH17-212

- 90 pg/mL Control 2 6.1 - 13 ng/mL Control 2 444- 923 pg/mL IFNG Control 1 109 - 263 pg/mL IL-4 Control 1 0.21 - 0.43

RABBIT ANTI-MOUSE AGGRECAN POLYCLONAL ANTIBODY

(951) 676-9209 • Europe +44 (0) 23 8026 2233 Australia +61 3 9839 2000 www.millipore.com 01-24-08/AB8135/JLH Zhang, J. and Nicholson, B. (1989) J. Cell Biol. 109: 3391-3401. Nicholson

Prohibited Product List Korean

96-34-4 1차 2020-08-25 8.02413.1000 802413 METHYL CHLOROACETATE FOR SYNTHESIS 96-34-4 1차 2020-08-25 8.01809.0100 801809 BENZYL CHLORIDE FOR SYNTHESIS

The Effective Use of Protein Kinase Inhibitors

95 91 106 98 65 104 73 102 96 95 78 98 105 60 75 86 69 15 20 86 82 69 114 115 27 46 105 109 99 44 54 92 4 5 5 29 23 5

Data Sheet - P1985

al., Proc. Natl. Acad. Sci. USA, 71, 1207 (1974). 3. Pierce, g., et al., J. Cell. Biol., 109, 429 (1989). 4. Ross, R., Arteriosclerosis, 1, 293, (1981). 5. Heldin, C.H., and Westermark, B., Physiol.

Quality Control Range Sheet- A60MG-104 and A60MG-204

Control 2 100 - 208 pg/mL Control 2 4712 - 9787 pg/ml IL-4 Control 1 22 - 46 pg/mL IL-18 Control1 17 – 36 pg/ml Control 2

Data Sheet - F1884 - Lot 097H888041

180 200 220 0 50000 100000 150000 200000 250000 m/z Abundance 44 56 72 89 99 109 119 127 141 151 159 169 187 192 200 216 230

Mobius® FlexReady Solution for Large Scale Clarification

/ 11m² Available flux (LMH) w/ 22m² Available flux (LMH) w/ 33m² 109 to 327 L/h/m² 109 to 163 L/h/m² Up to 109 L/h/m² 4 Description Specifications Pumps Brand: Model: Number: Flow

Charged filter endotoxin removal performance comparison

that both positively charged membranes exhibited average endotoxin removal capacities of 2±0.92 x 109 EU/m2 in a non-ionic solution. Test Overview During this study, flux and the capacity of Charged

Attachment and Matrix Factors - V0132

, M. (1989). J. Cell Biol., 109: 1309-1319. 42. Roberts, D. R., et al. (1987). J. Cell Biol., 104: 131-139. 43. Robey, P. G., et al. (1989). J. Cell. Biol., 108: 719-727. 44. Santoro, S. A. and Frazier

Attachment and Matrix Factors - V8379

, M. (1989). J. Cell Biol., 109: 1309-1319. 42. Roberts, D. R., et al. (1987). J. Cell Biol., 104: 131-139. 43. Robey, P. G., et al. (1989). J. Cell. Biol., 108: 719-727. 44. Santoro, S. A. and Frazier

Attachment and Matrix Factors - V9881

, M. (1989). J. Cell Biol., 109: 1309-1319. 42. Roberts, D. R., et al. (1987). J. Cell Biol., 104: 131-139. 43. Robey, P. G., et al. (1989). J. Cell. Biol., 108: 719-727. 44. Santoro, S. A. and Frazier

Quality Control Range Sheet- A60MG-105 and A60MG-205

-1β Control 1 48 - 99 pg/mL IL-17A Control1 44 - 92 pg/ml Control 2 234 - 486 pg/mL Control 2 216 - 448 pg/ml

Quality Control Ranges: Human Cytokine/ Chemokine/Growth Factor Magnetic Bead Panel A

pg/ml IL-2 Control 1 19 - 44 pg/mL IL-17F Control1 877 - 1949 pg/ml Control 2 105 - 219 pg/mL Control 2 4401

The Effective Use of Protein Kinase Inhibitors

95 91 106 98 65 104 73 102 96 95 78 98 105 60 75 86 69 15 20 86 82 69 114 115 27 46 105 109 99 44 54 92 4 5 5 29 23 5

Data Sheet - P2110

al., Proc. Natl. Acad. Sci. USA, 71, 1207 (1974). 3. Pierce, g., et al., J. Cell. Biol., 109, 429 (1989). 4. Ross, R., Arteriosclerosis, 1, 293, (1981). 5. Heldin, C.H., and Westermark, B., Physiol.

Data Sheet - F1884 - Lot 111K8811

50000 100000 150000 200000 250000 300000 350000 m/z Abundance 44 56 63 72 89 99 109 119 127 141 151 159 169 187 192 200 216

Proteomics Prod Guide

Strain Background K12 K12 K12 K12 K12xB B B B B Transformation Efficiency (cfu/mg pUC plasmid DNA) 109 109 1010 108 108 106 106 106 106 Cloning Strain ÷ ÷ ÷ ÷ ÷ Expression Strain ÷ ÷ ÷ ÷ Blue/White Selection

Data Sheet - F1884 - Lot 92K8802

60000 80000 100000 120000 140000 160000 180000 m/z Abundance 44 56 72 89 95 109 119 127 141 151 159 169 187 198 216 230 Hewlett-Packard 5890

Improved Method for Adenovirus and Lentivirus Purification using the Fast-Trap™ Virus Purification and Concentration Kit

Double CsCl Gradient Amount crude adenovirus (ivp) 5.81 x 109 5.81 x 109 Amount purified adenovirus (ivp) 4.05 x 109 2.64 x 109 % virus recovery 70 45 Table 1. Adenovirus purification

PKH Dye Reference Guide

and/or fusion 1-3, 12, 34, 60, 64, 85, 103, 109, 136, 137 Cytotoxicity, immunotherapy 10, 28, 44, 73, 93, 105 Phagocytosis 21, 25, 34, 37, 38, 44, 113, 117, 166 Cell-cell communication

Quality Control Range Sheet- FCY-108 and FCY-208

pg/mL IL-13 Control 1 109 – 226 pg/mL IL-18 Control 1 961 – 1997 pg/mL Control 2 825 – 1713 pg/mL Control 2 7785 –

Comparison of Chromogenic Coliform Agar Membrane Filter Sets For Water Filtration Applications

Aerogenes WDCM 00175 C. freundil WDCM 00006 ReadyPlate™ 55 CCA 99 109 95 103 Company A 33 2 22 7 Company B 72 42 36 44 0 20 40 60 80 100

Product Information Sheet - D1626

(1957). 3. Marmur, J., and Doty, P., J. Mol. Biol., 5, 109-118 (1962). 4. Tanaka, K., and Okahata, Y., J. Am. Chem. Soc., 118(44), 10679-10683 (1996). 5. Sambrook, J., et al., in Molecular

TB029

2833 3774 MwoI 27 NarI 4 185 206 320 977 NciI 9 306 1030 1256 1584 1890 1925 2626 3322 3673 NdeI 1 44 NgoAIV 4 172 540 700 1054 NheI 1 37 NlaIII 25 NlaIV 21 NruI 1 745 NspI 4 337 1591 1883 2250 Pfl1108I